Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Arnett

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Immunology|June 3, 2021
Magnetic resonance imaging in neuromyelitis optica spectrum disorderLaura Clarke, Simon Arnett, Kate Lilley, et al.
Multiple Sclerosis and Related Disorders|January 30, 2022
Low vitamin D levels do not predict risk of autoimmune disease following alemtuzumab treatment for multiple sclerosisSimon Arnett, Sofia Jimenez Sanchez, Jennifer Downing, et al.
Multiple Sclerosis and Related Disorders|July 30, 2025
Treatment outcomes in multiple sclerosis using reduced and extended interval ocrelizumab dosingAntonia McLean, Simon Arnett, Joshua Yap, et al.
Journal of Neurology|July 3, 2024
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysisSimon Arnett, Sin Hong Chew, Unnah Leitner, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Response to treatment in NMOSD: the Australasian experienceLaura Clarke, Wajih Bukhari, Cullen M O'Gorman, et al.
Radiology|November 12, 2024
Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study CohortClaudia Chien, Vera Cruz E Silva, Emanuel Geiter, et al.
Journal of Neurology|February 2, 2020
The clinical profile of NMOSD in Australia and New ZealandWajih Bukhari, Laura Clarke, Cullen O'Gorman, et al.
Frontiers in Neurology|July 3, 2020
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal VariationElham Khalilidehkordi, Laura Clarke, Simon Arnett, et al.
Frontiers in Neurology|September 27, 2021
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple SclerosisLaura Clarke, Simon Arnett, Wajih Bukhari, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Immunology|June 3, 2021
Magnetic resonance imaging in neuromyelitis optica spectrum disorderLaura Clarke, Simon Arnett, Kate Lilley, et al.
Multiple Sclerosis and Related Disorders|January 30, 2022
Low vitamin D levels do not predict risk of autoimmune disease following alemtuzumab treatment for multiple sclerosisSimon Arnett, Sofia Jimenez Sanchez, Jennifer Downing, et al.
Multiple Sclerosis and Related Disorders|July 30, 2025
Treatment outcomes in multiple sclerosis using reduced and extended interval ocrelizumab dosingAntonia McLean, Simon Arnett, Joshua Yap, et al.
Journal of Neurology|July 3, 2024
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysisSimon Arnett, Sin Hong Chew, Unnah Leitner, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Response to treatment in NMOSD: the Australasian experienceLaura Clarke, Wajih Bukhari, Cullen M O'Gorman, et al.
Radiology|November 12, 2024
Aquaporin-4 Immunoglobulin G-seropositive Neuromyelitis Optica Spectrum Disorder MRI Characteristics: Data Analysis from the International Real-World PAMRINO Study CohortClaudia Chien, Vera Cruz E Silva, Emanuel Geiter, et al.
Journal of Neurology|February 2, 2020
The clinical profile of NMOSD in Australia and New ZealandWajih Bukhari, Laura Clarke, Cullen O'Gorman, et al.
Frontiers in Neurology|July 3, 2020
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal VariationElham Khalilidehkordi, Laura Clarke, Simon Arnett, et al.
Frontiers in Neurology|September 27, 2021
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple SclerosisLaura Clarke, Simon Arnett, Wajih Bukhari, et al.
Pageof 1